|
G.D. Tarasova (1, 2)
THE USE OF LEVOFLOXACINE IN OTORHINOLARYNGOLOGY: FEATURES AND ADVANTAGES
|
№10 / 2017
|
|
E.A. Ushkalova, S.K. Zyryanov
LEVOFLOXACIN: BENEFIT-RISK RATIO
|
№s2-17 / 2017
|
|
N.V. Zaharova (1), V.I. Simanenkov (1), I.V. Savilova (1), A.V. Svarval (2)
HELICOBACTER PYLORI - ISOTOPIC DIAGNOSIS OF INFECTION AND TESTING OF RESISTANCE
|
№2 / 2016
|
|
A.A. Samsonov (1), D.N. Andreev (1), V.B. Grechushnikov (2), R.A. Aivazova (1)
RESISTANCE OF HELICOBACTERPYLORI TO THE COMPONENTS OF ERADICATION THERAPY AND WAYS FOR ITS OVERCOMING
|
№2 / 2015
|
|
S.K.Zyryanov 1, Yu.B.Belousov 1, A.V.Kamayev 2, A.A.Lelishentsev 2, Yu.B, Zverkov 2
Efficacy Of Use Of Levofloxacin – Factors Of Success
|
№10 / 2012
|
|
Zh.A. Galeyeva, S.K. Zyryanov
Levofloxacin In The Treatment Of Community-acquired Pneumonia: Whether Advantages Are Obvious?
|
№5 / 2012
|
|
Ye.A. Sultanova, Ye.V. Shpot
Application Of Levolet (levofloxacin) In Urology
|
№13 / 2011
|
|
I.B. Angotoyeva
Efficacy And Safety Of Levolet In Patients With Acute Bacterial Rhinosinusitis And Exacerbations Of Chronic Purulent Rhinosinusitis
|
№10 / 2011
|
|
Nonikov V.E., Myshyakov V.I.
Levofloxacin (tavanic) In The Treatment Of Pneumonia
|
№4 / 2011
|
|
Dvoreckii L.I.
Antibiotic Therapy Of Infectious Exacerbations Of Chronic Obstructive Pulmonary Disease: Patients With The Risk Of Poor Response To Antibiotics
|
№4 / 2011
|
|
V.Nonikov
Respiratory Tract Infections And The Fluoroquinolones Of The Latest Generations
|
№4 / 2010
|
|
Romanovski A. G., Sinopalnikov A. I. С. 8690
Antibacterial Therapy Of Infectious Exacerbation Of Copd: Which Antibiotic To Prefer?
|
№20 / 2009
|
Русский
